Alejandro Hoberman, MD

Chief, Division of General Academic Pediatrics
University of Pittsburgh School of Medicine

Disclosure(s): Kaizen Biosciences: Advisor/Consultant, Stocks/Bonds (Private Company)

Poster(s):

• (P-1241) Pharmacokinetic Comparison of Augmentin ES-600 and a Reduced Concentration Clavulanate Formulation in Young Children; Modeling of amoxicillin/clavulanic acid in vitro effects on bacterial growth and killing and in vivo exposure evaluation
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET